- Home
- LFCR vs STXS Comparison
LFCR vs STXS Comparison
Compare LFCR & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- STXS
- Stock Information
- Founded
- LFCR 1986
- STXS 1990
- Country
- LFCR United States
- STXS United States
- Employees
- LFCR N/A
- STXS N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LFCR Health Care
- STXS Health Care
- Exchange
- LFCR Nasdaq
- STXS Nasdaq
- Market Cap
- LFCR 288.0M
- STXS 275.9M
- IPO Year
- LFCR N/A
- STXS 2004
- Fundamental
- Price
- LFCR $6.62
- STXS $3.11
- Analyst Decision
- LFCR Buy
- STXS
- Analyst Count
- LFCR 4
- STXS 0
- Target Price
- LFCR $8.00
- STXS N/A
- AVG Volume (30 Days)
- LFCR 231.6K
- STXS 582.5K
- Earning Date
- LFCR 10-03-2025
- STXS 11-10-2025
- Dividend Yield
- LFCR N/A
- STXS N/A
- EPS Growth
- LFCR N/A
- STXS N/A
- EPS
- LFCR N/A
- STXS N/A
- Revenue
- LFCR $128,867,000.00
- STXS $31,806,000.00
- Revenue This Year
- LFCR $4.71
- STXS $30.98
- Revenue Next Year
- LFCR $10.98
- STXS $49.86
- P/E Ratio
- LFCR N/A
- STXS N/A
- Revenue Growth
- LFCR 0.47
- STXS 33.94
- 52 Week Low
- LFCR $4.59
- STXS $1.54
- 52 Week High
- LFCR $8.85
- STXS $3.59
- Technical
- Relative Strength Index (RSI)
- LFCR 40.90
- STXS 52.79
- Support Level
- LFCR $6.44
- STXS $2.94
- Resistance Level
- LFCR $6.82
- STXS $3.20
- Average True Range (ATR)
- LFCR 0.30
- STXS 0.20
- MACD
- LFCR -0.02
- STXS -0.03
- Stochastic Oscillator
- LFCR 22.13
- STXS 25.95
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.